Feline immunodeficiency virus vaccine: implications for diagnostic testing and disease management

Area of Science:

• Veterinary Virology
• Immunology
• Epidemiology

Background:

• Feline immunodeficiency virus (FIV) is a widespread feline pathogen affecting approximately 11% of cats globally.
• FIV infection leads to immunosuppression, increasing susceptibility to secondary infections and often resulting in a fatal outcome.
• Current FIV diagnosis relies on detecting virus-specific antibodies, which is complicated by existing vaccines.

Purpose of the Study:

• To evaluate the diagnostic challenges posed by current FIV vaccines.
• To assess the inability of diagnostic tests to differentiate between FIV infection and vaccination.
• To analyze the implications for epidemiological studies and individual cat health management.

Main Methods:

• Review of current FIV diagnostic methodologies.
• Analysis of antibody responses induced by FIV infection versus vaccination.
• Evaluation of the limitations of existing diagnostic tests in vaccinated and/or infected cats.

Main Results:

• The currently available inactivated FIV vaccine produces antibodies indistinguishable from those generated by natural FIV infection.
• Existing diagnostic tests cannot reliably differentiate between vaccinated cats, infected cats, or cats that are both vaccinated and infected.
• This diagnostic ambiguity prevents accurate assessment of FIV prevalence and vaccine efficacy.

Conclusions:

• The inability to distinguish vaccination from infection poses significant challenges for FIV epidemiology and clinical management.
• The current diagnostic limitations make it difficult to ascertain the net benefit versus harm of FIV vaccination.
• Further development of diagnostic tools is crucial for effective FIV control and understanding vaccine impact.